Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Retinoblastoma 1Rectal Neoplasms 1Polycystic Ovary Syndrome 1Lung Neoplasms 1Infertility, Female 1Hypoxia 1Esophageal Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Oxaliplatin 271Fluorouracil 268Capecitabine 234Leucovorin 209Irinotecan 152Radiotherapy 138Bevacizumab 114Cetuximab 82Surgical Procedures, Operative 51Folfox protocol 48Neoadjuvant Therapy 45Drug Therapy 43Radiation 42Chemotherapy, Adjuvant 34Chemoradiotherapy 34Panitumumab 27Magnetic Resonance Spectroscopy 26XELOX 25Radiotherapy, Intensity-Modulated 23Biopsy 20Surveys and Questionnaires 18Laparoscopy 18Proctectomy 17Floxuridine 17Early Intervention, Educational 16Nivolumab 15Immunohistochemistry 15Gene Expression Profiling 15Gemcitabine 15pembrolizumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Nitroglycerin × Clear all
NCT01407107 2021-01-14

Dose Escalation Trial of Nitroglycerin, 5-flourouracil and Rad Therapy for Rectal Cancer

University of Texas Southwestern Medical Center

Phase 1 Completed
13 enrolled 8 charts
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡